Showing results (91-100 of 446) with videos related to
Sort By:
Pageof 45
Cold Spring Harbor Perspectives in Biology|May 28, 2024
Multiple Sclerosis and Other Acquired Demyelinating Diseases of the Central Nervous SystemMichael D Kornberg, Peter A CalabresiMultiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2019
Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinningElias S Sotirchos, Angeliki Filippatou, Kathryn C Fitzgerald, et al.Journal of Neurology|March 16, 2012
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniquesMichaela A Seigo, Elias S Sotirchos, Scott Newsome, et al.Current Opinion in Pharmacology|March 7, 2022
Breaking the barriers to remyelination in multiple sclerosisMarjan Gharagozloo, Riley Bannon, Peter A CalabresiJournal of Neuroimmunology|February 12, 2015
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controlsPavan Bhargava, Anne Gocke, Peter A CalabresiAnnals of Neurology|July 21, 2015
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year studyShiv Saidha, Omar Al-Louzi, John N Ratchford, et al.Neurology|March 22, 2013
In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaElias S Sotirchos, Shiv Saidha, Gita Byraiah, et al.Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with SeverityFatemeh Siavoshi, Julián Candia, Dimitrios C Ladakis, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 30, 2026
Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple SclerosisAnna Bacchetti, Brenna McCormack, Ting-Yi Lin, et al.Neurology|April 8, 2021
Modulation of Retinal Atrophy With Rituximab in Multiple SclerosisJeffrey Lambe, Hunter Risher, Angeliki G Filippatou, et al.Pageof 45